Clinical trial
The Use of Cilostazol in Patients With Diabetic Nephropathy
NCT00272831 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00272831 |
|---|---|
| Title | The Use of Cilostazol in Patients With Diabetic Nephropathy |
| Official title | A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100 mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Diabetes Complications |
| Intervention type | Drug |
| Interventions | Cilostazol, Placebo |
| Enrollment | 62 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 9, 2006 |
| Last update posted | May 22, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: